BTTR / SRx Health Solutions Inc. - SEC申報文件，年度報告，委任書

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 SRx Healt

SRx HEALTH SOLUTIONS, INC. INFORMATION STATEMENT/PROSPECTUS AND NOTICE OF ACTION BY WRITTEN CONSENT WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE NOT REQUESTED TO SEND US A PROXY TO THE STOCKHOLDERS OF SRx HEALTH SOLUTIONS, INC.

Filed Pursuant to Rule 424(b)(3) Registration Statement 333-295049 PROSPECTUS SRx HEALTH SOLUTIONS, INC.

Security Type

Calculation of Filing Fee Tables S-4 SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward

As filed with the Securities and Exchange Commission on May 5, 2026

As filed with the Securities and Exchange Commission on May 5, 2026 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 22, 2026 SRx Health Solutio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 22, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital Company has invested greater than 10 % of its investable capital in the convergence of Artificial Intelligence (“AI”) and space through Astro Capital

Exhibit 99.1 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital Company has invested greater than 10 % of its investable capital in the convergence of Artificial Intelligence (“AI”) and space through Astro Capital NORTH PALM BEACH, FL — April 22, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 17, 2026 SRx Health Solutio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 17, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between SRx Health Solutions and EMJX

Exhibit 99.1 SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between SRx Health Solutions and EMJX NORTH PALM BEACH, FL — April 17, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”

As filed with the Securities and Exchange Commission on April 14, 2026

As filed with the Securities and Exchange Commission on April 14, 2026 Registration No.

Security Type

Calculation of Filing Fee Tables S-4 SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward

CERTIFICATE OF DESIGNATIONS OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK OF SRX HEALTH SOLUTIONS INC.

Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK OF SRX HEALTH SOLUTIONS INC. I, Carolina Martinez, hereby certify that I am the Chief Financial Officer, Secretary and Treasurer of SRx Health Solutions Inc., (the “Company”), a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), and further do hereby ce

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 16, 2026, is by and among SRx Health Solutions Inc., a Delaware corporation with offices located at 801 US Highway 1, North Palm Beach, Florida 33408 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2026 SRx Health Solutio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

REGISTRATION RIGHTS AGREEMENT

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March , 2026, is by and among SRx Health Solutions Inc., a Delaware corporation with offices located at 801 US Highway 1, North Palm Beach, Florida 33408 (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”). RECITALS A. In connection with the Securi

SRx Health Solutions Inc. Warrant To Purchase Common Stock

Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

SRx HEALTH SOLUTIONS, INC. Up to 187,544,974 Shares of Common Stock Offered by the Selling Stockholders

PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3) To Prospectus Dated December 30, 2025 Under the Securities Act of 1933 in connection with Registration Statement No.

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3) To Prospectus Dated December 15, 2025 Under the Securities Act of 1933 in connection with Registration Statement No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 2, 2026 SRx Health Solution

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 2, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

LIMITED WAIVER AND CONSENTAGREEMENT

Exhibit 10.1 LIMITED WAIVER AND CONSENTAGREEMENT This Limited Waiver and Consent Agreement (the “Agreement”), dated as of March 2, 2026, is by and between SRx Health Solutions Inc., a Delaware corporation (the “Company”), and the holder identified on the signature page hereto (the “Holder”). R E C I T A L S A. Reference is made to (i) that certain Securities Purchase Agreement, dated as of July 7,

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3) To Prospectus Dated December 15, 2025 Under the Securities Act of 1933 in connection with Registration Statement No.

SRx HEALTH SOLUTIONS, INC. Up to 187,544,974 Shares of Common Stock Offered by the Selling Stockholders

PROSPECTUS SUPPLEMENT To Prospectus Dated December 30, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

SRx HEALTH SOLUTIONS, INC. Up to 187,544,974 Shares of Common Stock Offered by the Selling Stockholders

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2026 SRx Health Solu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

SRx Health Solutions Announces Receipt of Warning Letter from NYSE American

Exhibit 99.2 FOR IMMEDIATE RELEASE SRx Health Solutions Announces Receipt of Warning Letter from NYSE American NORTH PALM BEACH, FL — February 20, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced that on February 18, 2026, it received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifyin

11 Wall Street

Exhibit 99.1 Tony Frouge Chief Regulatory Officer New York Stock Exchange 11 Wall Street New York, NY 10005 T + 1 212 656 2133 [email protected] February 18, 2026 Mr. Kent Cunningham Chief Executive Officer SRX Health Solutions, Inc. 801 US Highway 1 North Palm Beach, Florida 33408 Dear Mr. Cunningham: NYSE Regulation is issuing this public Warning Letter to SRX Health Solutions, Inc. (the “Com

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 SRx He

EX-19

Exhibit 19

SRx HEALTH SOLUTIONS, INC. Up to 187,544,974 Shares of Common Stock Offered by the Selling Stockholders

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders

Exhibit 99.1 FOR IMMEDIATE RELEASE SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders NORTH PALM BEACH, FL — February 11, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced that it has redeemed 17,500 sh

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2026 SRx Health Solut

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2026 SRx Health Soluti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2026 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

SRx Health Solutions Regains Compliance with NYSE

Exhibit 99.1 SRx Health Solutions Regains Compliance with NYSE NORTH PALM BEACH, FL — January 8, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced that the NYSE American (“NYSE”) has accepted the Company’s plan to regain compliance with the continued listing standards in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. As previously disclosed,

SRx HEALTH SOLUTIONS, INC. Up to 187,544,974 Shares of Common Stock Offered by the Selling Stockholders

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

SRx HEALTH SOLUTIONS, INC. Up to 187,544,974 Shares of Common Stock Offered by the Selling Stockholders

Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

As filed with the Securities and Exchange Commission on December 22, 2025

As filed with the Securities and Exchange Commission on December 22, 2025 Registration No.

CALCULATION OF FILING FEE TABLES SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 CALCULATION OF FILING FEE TABLES S-1 SRx Health Solutions, Inc. 333-291395 Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Sh

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2025 SRx Health Solu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 16, 2025 SRx Health Solu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 16, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson Upon closing, Eric M. Jackson to Lead Combined Company as Chief Executive Officer and

Exhibit 99.1 SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson Upon closing, Eric M. Jackson to Lead Combined Company as Chief Executive Officer and Chairman NORTH PALM BEACH, FL — December 16, 2025 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced tha

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

PROSPECTUS SUPPLEMENT To Prospectus Dated December 15, 2025 Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

EX-99.2

Exhibit 99.2

SHARE EXCHANGE AND ASSET TRANSFER AGREEMENT

Exhibit 2.1 SHARE EXCHANGE AND ASSET TRANSFER AGREEMENT THIS SHARE EXCHANGE AND ASSET TRANSFER AGREEMENT is made and entered into as of December 16, 2025 (this “Agreement”) by and among SRx Health Solutions, Inc., a Delaware corporation (“SRXH”), EMJ Crypto Technologies Inc., an Ontario corporation (“EMJC”), CCC Crypto Corp, a Delaware corporation (“DelawareCo”, and together with EMJC, the “Acquir

SRx HEALTH SOLUTIONS, INC. Up to 2,506,893,959 Shares of Common Stock Offered by the Selling Stockholder

Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933 in connection with Registration Statement No.

CALCULATION OF FILING FEE TABLES SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 CALCULATION OF FILING FEE TABLES S-1 SRx Health Solutions, Inc. 333-291262 Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Sh

SRx Health Solutions, Inc. 801 US Highway 1 North Palm Beach, FL 33408

SRx Health Solutions, Inc. 801 US Highway 1 North Palm Beach, FL 33408 December 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Randy Acker Re: SRx Health Solutions, Inc. Registration Statement on Form S-1 Filed on November 4, 2025 File No. 333-291262 Ladies and Gentlemen: Pursuant

As filed with the Securities and Exchange Commission on December 10, 2025

As filed with the Securities and Exchange Commission on December 10, 2025 Registration No.

EX-19

Exhibit 19

EX-3.10

Exhibit 3.10

AMENDED AND RESTATED SRx HEALTH SOLUTIONS, INC. As Adopted on October 8, 2025 Article I. Meetings of Shareholders

Exhibit 3.11 AMENDED AND RESTATED BYLAWS OF SRx HEALTH SOLUTIONS, INC. As Adopted on October 8, 2025 Article I. Meetings of Shareholders Section 1. Annual Meeting. The annual meeting of shareholders of SRx Health Solutions, Inc. (formerly known as Better Choice Company, Inc.) (the “Company”) shall be held at the time and place designated by the Board of Directors of the Company. Business transacte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 SRx Health So

CERTIFICATE OF AMENDMENT CERTIFICATE OF INCORPORATION SRX HEALTH SOLUTIONS, INC.

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF SRX HEALTH SOLUTIONS, INC. SRx Health Solutions, Inc., a corporation organized and existing and by virtue of the General Corporation Law of the State of Delaware (the “Company”), hereby certifies as follows: 1. The name of the Company is SRx Health Solutions, Inc., and the original Certificate of Incorporation of the Company w

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 19, 2025 SRx Health Solu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 19, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2025 SRx Health Solu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

SRx Health Solutions Appoints Sammy Dorf to Board of Directors

Exhibit 99.1 SRx Health Solutions Appoints Sammy Dorf to Board of Directors TAMPA, FL, November 10, 2025 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry’s most accomplished dealmakers, strategists, and growth architects

CALCULATION OF FILING FEE TABLES SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 CALCULATION OF FILING FEE TABLES S-1 SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Shares of com

As filed with the Securities and Exchange Commission on November 7, 2025

As filed with the Securities and Exchange Commission on November 7, 2025 Registration No.

CALCULATION OF FILING FEE TABLES SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 CALCULATION OF FILING FEE TABLES S-1 SRx Health Solutions, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Shares of com

As filed with the Securities and Exchange Commission on November 4, 2025

As filed with the Securities and Exchange Commission on November 4, 2025 Registration No.

CERTIFICATE OF DESIGNATIONS OF RIGHTS AND PREFERENCES OF SERIES A CONVERTIBLE PREFERRED STOCK OF SRX HEALTH SOLUTIONS INC.

Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF RIGHTS AND PREFERENCES OF SERIES A CONVERTIBLE PREFERRED STOCK OF SRX HEALTH SOLUTIONS INC. I, Carolina Martinez, hereby certify that I am the Chief Financial Officer, Secretary and Treasurer of SRx Health Solutions Inc., (the “Company”), a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), and further do hereby ce

[The remainder of the page is intentionally left blank]

Exhibit 10.3 AMENDMENT THIS AMENDMENT (this “Amendment”) is entered into by and between SRx Health Solutions Inc., a Delaware corporation (the “Company”) and Keystone Capital Partners, LLC, a Delaware limited liability company (“Keystone”) as of this 28th day of October, 2025. A. The Company previously entered into that certain Common Stock Purchase Agreement, by and between the Company and Keysto

REGISTRATION RIGHTS AGREEMENT

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October , 2025, is by and among SRx Health Solutions Inc., a Delaware corporation with offices located at 12400 Race Track Road, Tampa, FL 33626 (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”). RECITALS A. In connection with the Securities Purc

SRx Health Solutions Inc. Warrant To Purchase Common Stock

Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 27, 2025, is by and among SRx Health Solutions Inc., a Delaware corporation with offices located at 12400 Race Track Road, Tampa, FL 33626 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buye

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2025 SRx Health Solut

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement SRX HEALTH SOLUTIONS, INC. (Name of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 14, 2025 SRx Health Solut

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 14, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commis

SRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency

Exhibit 99.1 SRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency TAMPA, FL, October 17, 2025 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced it received a notice from the staff of NYSE American LLC (the “Exchange”) that the Company was not in compliance with the Exchange’s continued listing standards under Sec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 9, 2025 SRx Health Soluti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 9, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction (Commission (IRS Employer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement SRX HEALTH SOLUTIONS, INC. (Name of

SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

Exhibit 99.1 SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) - SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking Statements This press release contains forward-looking stateme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2025 SRx Health Soluti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

EX-21.1

Exhibit 21.1 Entity name Principal activity State/Province 3788602 Manitoba Ltd. Pharmacy MB Alberta Specialty Rx Inc. Pharmacy AB Edmonton SRX Inc. Pharmacy AB RX Solutions Inc. Pharmacy MB SRX Health Initiatives Inc. Patient support programs ON SRX Island Holdings Inc. (2) Pharmacy BC SRX NS Inc. Pharmacy NS SRX Pharma Inc. Pharmacy SK TDDA SR SMO Inc. Clinical Trials ON Toronto Digestive Diseas

EX-19

Exhibit 19

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 SRx Health

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 15, 2025 SRx Health Sol

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 15, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Comm

September 19, 2025

Exhibit 16.1 September 19, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by SRx Health Solutions, Inc.under Item 4.01 of its Form 8-K dated September 15, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of SRx Health Solutions

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement SRX HEALTH SOLUTIONS, INC. (Name of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB Number: 3235-0058 Expires: August 31, 2025 Estimated average burden hours per response................ 2.50 SEC FILE NUMBER CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 13, 2025 SRx Health Soluti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 13, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

SETTLEMENT, SHARE FORFEITURE AND MUTUAL RELEASE AGREEMENT

Exhibit 10.1 SETTLEMENT, SHARE FORFEITURE AND MUTUAL RELEASE AGREEMENT This Share Forfeiture Agreement (this “Agreement”) is made as of August 1, 2025, by and among SRx Health Solutions, Inc., a Delaware corporation (formerly known as Better Choice Company, Inc.) (“DE Parent”), SRx Health Solutions (Canada) Inc., a corporation existing under the laws of the Province of Ontario (“ON Sub” and togeth

SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock The Company intends to explore all available legal remedies against former officers of SRx Canada

Exhibit 99.1 SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock The Company intends to explore all available legal remedies against former officers of SRx Canada TAMPA, FL, August 14, 2025 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that further to the previo

SRx Health Solutions Initiates Restructuring Proceedings under CCAA for its Canadian Subsidiary U.S. operations, including Halo subsidiary, will not be affected by CCAA Proceedings; No U.S. bankruptcy filing expected

Exhibit 99.1 SRx Health Solutions Initiates Restructuring Proceedings under CCAA for its Canadian Subsidiary U.S. operations, including Halo subsidiary, will not be affected by CCAA Proceedings; No U.S. bankruptcy filing expected TAMPA, FL, August 12, 2025 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that its subs

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2025 SRx Health Soluti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

Exhibit 99.2 SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary TAMPA, FL, August 12, 2025 - SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.(“SRx Canada”) and certain of its subsidiaries obtained an Initial Order (the “Initial Order

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement SRX HEALTH SOLUTIONS, INC. (Name of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2025 SRx Health Solution

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT SRX HEALTH SOLUTIONS, INC. AND CAROLINA MARTINEZ

Exhibit 10.2 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT BETWEEN SRX HEALTH SOLUTIONS, INC. AND CAROLINA MARTINEZ This Amendment No. 1 to Employment Agreement (this “Amendment”) is made and entered into as of July 14, 2025 (the “Amendment Effective Date”) by and between SRx Health Solutions, Inc., a Delaware corporation (f/k/a Better Choice Company, Inc., the “Company”) and Caolina Martinez (the “Exec

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 14, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

SRx Health Solutions Announces Management and Board Changes

Exhibit 99.1 SRx Health Solutions Announces Management and Board Changes TAMPA, FL, July 14, 2025 (GLOBE NEWSWIRE) - SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the appointment of current President, Kent Cunningham, as CEO, and current CEO, Adesh Vora, as Executive Chairman effective immediately. About SRx Health S

EMPLOYMENT AGREEMENT

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of July 14, 2025 (the “Effective Date”) and is entered into by and between Kent Cunningham, residing at [redacted] (the “Executive”) and SRx Health Solutions Inc., a Delaware Corporation (the “Company”). The Company and Executive shall be referred to herein as the “Parties.” RECITALS WHEREAS, the Company des

REGISTRATION RIGHTS AGREEMENT

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July [ ], 2025, is by and between [●] (the “Investor”), and SRx Health Solutions Inc., a Delaware corporation (the “Company”). RECITALS A. The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), pu

SRx Health Solutions Inc. Senior Secured Convertible Note

Exhibit 10.4 EXECUTION VERSION NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRAT

SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million

Exhibit 99.1 SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million TAMPA, FL, July 8, 2025 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRX Health” or the “Company”), a leading global health and wellness company, today announced the successful closing of a $7.3 million convertible note fin

SECURITY AND PLEDGE AGREEMENT

Exhibit 10.6 SECURITY AND PLEDGE AGREEMENT SECURITY AND PLEDGE AGREEMENT, dated as of July 3, 2025 (this “Agreement”), made by SRx Health Solutions Inc., a company organized under the laws of Delaware, with offices located at 12400 Race Track Road, Tampa, FL 33636 (the “Company”), and each of the undersigned direct and indirect and direct Subsidiaries (as defined below) of the Company from time to

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 7, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission

REGISTRATION RIGHTS AGREEMENT

Exhibit 10.7 EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 8, 2025, is by and among SRx Health Solutions Inc., a Delaware corporation with offices located at 12400 Race Track Road, Tampa, FL 33626 (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”). RECITALS A. In connection with the

SECURITIES PURCHASE AGREEMENT

Exhibit 10.3 EXECUTION VERSION SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 7, 2025, is by and among SRx Health Solutions Inc., a Delaware corporation with offices located at 12400 Race Track Road, Tampa, FL 33626 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectiv

SRx Health Solutions Inc. Warrant To Purchase Common Stock

Exhibit 10.5 EXECUTION VERSION NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRAT

COMMON STOCK PURCHASE AGREEMENT

Exhibit 10.l COMMON STOCK PURCHASE AGREEMENT This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of July 3, 2025 (this “Agreement”), by and among [●] (the “Investor”), and SRx Health Solutions Inc., a Delaware corporation (the “Company”). RECiTALS WHEREAS, the parties desire that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and

Table of contents

Exhibit 99.1 SRX HEALTH SOLUTIONS INC. CONSOLIDATED FINANCIAL STATEMENTS For the years ended September 30, 2024 and 2023 (Expressed in thousands of Canadian dollars) Table of contents Report of Independent Registered Public Accounting Firm 3 Consolidated statements of financial position 4 Consolidated statements of operations 5 Consolidated statements of changes in shareholders’ deficit 6 Consolid

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2025 September 30, 2024 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction (Commi

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On April 24, 2025 (the “Closing Date”), SRx Health Solutions, Inc., a Delaware corporation (f/k/a Better Choice Company, Inc.) (the “Company”, “Registrant”, “Better Choice”, or “we”, “us” or “our”) completed a business combination (the “Business Combination”) by and among the Company, 1000994476 Ontario Inc., an Ontario corp

Table of contents

Exhibit 99.2 SRX HEALTH SOLUTIONS INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the three and six months ended March 31, 2025, and 2024 (Expressed in thousands of Canadian dollars) Table of contents Consolidated statements of financial position 3 Consolidated statements of operations 4 Consolidated statements of changes in shareholders’ deficit 5 Consolidated statements of cash flow

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 11, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

EX-99.2

Exhibit 99.2

SRx Health Solutions Announces Management and Board Changes

Exhibit 99.1 SRx Health Solutions Announces Management and Board Changes TAMPA, FL, June 11, 2025 (GLOBE NEWSWIRE) – SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the following management team and Board of Directors changes. Lionel Conacher, current Board member, has been appointed as Chairman of the Board, Adesh Vor

ORDER

UNITED STATES OF AMERICA BEFORE THE SECURITIES AND EXCHANGE COMMISSION June 3, 2025 In the Matter of SRx Health Solutions, Inc.

Insider Trading Policy

Exhibit 19.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 SRx Healt

SRx Health Solutions, Inc. Presentation dated May 6, 2024

Exhibit 99.2

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Subsidiaries of the Company

Exhibit 21.1 – Subsidiaries of the Company · Halo, Purely for Pets, Inc., a Delaware corporation · · Bona Vida, Inc., a Delaware corporation · · Aimia Pet Healthco, Inc., a corporation organized under the laws of Ontario, Canada · · 1000994085 Ontario, Inc., a corporation organized under the laws of Ontario, Canada · · SRx Health Solutions (Canada), Inc., a corporation organized under the laws of

Certificate of Amendment to Certificate of Incorporation, dated April 24, 2025

Exhibit 3.8 BETTER CHOICE COMPANY INC. CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That at a meeting of the Board of Directors of Better Choice Company Inc. resolutions were duly adopted setting forth a proposed amendment of the Certificate of

Certificate of Designation for Series A Special Voting Preferred Stock, filed April 24, 2025

Exhibit 3.8

Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price

Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 23, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Letter from Marcum dated April 29, 2025

Exhibit 16.1 April 29, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Better Choice Company Inc under Item 4.01 of its Form 8-K dated April 23, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Better Choice Company Inc. c

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 25, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025

Exhibit 99.1 SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025 TAMPA, FL, April 25, 2025 (GLOBE NEWSWIRE) – SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) (NYSE American: BTTR) (the “Company”), a leading global health and wellness company, today announced that it

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2025 Better Choice Company Inc. Better Choice Co Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of In

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2025 Better Choice Company Inc. Better Choice Co Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of In

Source: Better Choice Company Inc.

Exhibit 99.1 Source: Better Choice Company Inc. April 16, 2025 08:45 ET Better Choice Sells Halo’s Business in Asia for $8.1 Million in Total Gross Proceeds Including $6.5 Million in Cash Up Front, the Equivalent of $3.34 Per Share Better Choice will retain ownership of its North American operations and rest-of-world ex-Asia operations TAMPA, Fla., April 16, 2025 (GLOBE NEWSWIRE) — Better Choice C

Addendum to Arrangement Agreement and Plan of Arrangement

Exhibit 10.1 ADDENDUM TO ARRANGEMENT AGREEMENT AND PLAN OF ARRANGEMENT April 16, 2025 1. The undersigned are each a party to that certain Arrangement Agreement, dated as of September 3, 2024, as amended December 6, 2024, January 24, 2025 and February 25, 2025 (the “Agreement”) and that certain Plan of Arrangement, dated as of September 3, 2024, as amended January 24, 2025 and February 25, 2025 (th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Better Choice

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2025 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 27, 2025 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Press Release dated March 27, 2025

Exhibit 99.1

Subsidiaries of the Company

Exhibit 21.1

Insider Trading Policy

Exhibit 19

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of

Better Choice Company Adjourns Special Meeting of Stockholders to March 21, 2025

Exhibit 99.1 Better Choice Company Adjourns Special Meeting of Stockholders to March 21, 2025 TAMPA, FL, February 19, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that it convened its special meeting (“Special Meeting”) and immediately adjourned the meeting, with conducting any busin

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2025 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

Amendment No. 2 to Arrangement Agreement and Amendment No. 1 to Plan of Arrangement

Exhibit 10.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 24, 2025 Better Choice Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 24, 2025 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commis

LETTER

January 7, 2025 Kent Cunningham Chief Executive Officer Better Choice Co Inc. 12400 Race Track Road Tampa, FL 33626 Re: Better Choice Co Inc. Preliminary Proxy Statement on Schedule 14A Filed on December 26, 2024 File No. 001-40477 Dear Kent Cunningham: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of

U.S. Securities and Exchange Commission

January 6, 2025 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing Washington, D.C. 20549-3720 Attention: Bradley Ecker Jennifer Angelini Re: Better Choice Co Inc. Preliminary Proxy Statement on Schedule 14A Filed on December 26, 2024 File No. 001-40477 Dear Mr. Ecker: On behalf of our client, Better Choice Company, Inc. (“the “Company”), we submit this

LETTER

January 2, 2025 Kent Cunningham Chief Executive Officer Better Choice Co Inc. 12400 Race Track Road Tampa, FL 33626 Re: Better Choice Co Inc. Preliminary Proxy Statement on Schedule 14A Filed on December 26, 2024 File No. 001-40477 Dear Kent Cunningham: We have reviewed your filing and have the following comment(s). Please respond to this letter within ten business days by providing the requested

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 18, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

Amendment No. 1 to Arrangement Agreement

Exhibit 10.1

Press Release dated December 10, 2024

Exhibit 99.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2024 Better Choice Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

Press Release dated November 12, 2024

Exhibit 99.1

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 12, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

BTTR / Better Choice Company Inc. / Altium Capital Management LP - AMENDMENT TO SC 13G Passive Investment

SC 13G/A 1 bcc-sc13ga093024.htm AMENDMENT TO SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Better Choice Company Inc. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 08771Y402 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Bette

Joint Acquisition Statement Pursuant to Section 240.13d-1(k)

EX-1 2 ex1.htm JOINT ACQUISITION STATEMENT Better Choice Company Inc. Schedule 13G/A Page 9 of 9 EXHIBIT 1 JOINT ACQUISITION STATEMENT PURSUANT TO SECTION 240.13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each o

Better Choice Company Inc. Presentation dated October 30 2024

Exhibit 99.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2024 Better Choice Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 18, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition Combined company will emerge as a leading global health and wellness company by providing better prod

Exhibit 99.1 Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be approximately +$270 million, and +$10 m

Arrangement Agreement, dated September 3, 2024, between Better Choice Company Inc., and SRx Health Solutions, Inc., as amended December 6, 2024, January 24, 2025 and February 25, 2025

Exhibit 10.1 Execution Version ARRANGEMENT AGREEMENT by and among BETTER CHOICE COMPANY INC. and 1000994476 ONTARIO INC. and 1000994085 ONTARIO INC. and SRX HEALTH SOLUTIONS INC. September 3, 2024 SCHEDULES Schedule A Plan of Arrangement Schedule B SRx Arrangement Resolution Schedule C Representations and Warranties of SRx Schedule D Representations and Warranties of Parent Schedule E Key Regulato

Exhibt 99.2

Exhibt 99.2

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 3, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Comm

Voting Agreement dated September 3, 2024

Exhibit 10.2 FORM OF SRX VOTING AGREEMENT THIS AGREEMENT is made as of the 3rd day of September, 2024. BETWEEN: ADESH VORA, (the “Securityholder”) - and – BETTER CHOICE COMPANY INC., a corporation existing under the laws of the State of Delaware (“Better Choice”) WHEREAS the Securityholder is the registered and/or direct or indirect beneficial owner of the common shares (“SRx Shares”), restricted

Arrangement Agreement, dated September 3, 2024, between Better Choice Company Inc., and SRx Health Solutions, Inc., as amended December 6, 2024, January 24, 2025 and February 25, 2025

Exhibit 99.1

The date of this Offering Circular is , 2024 TABLE OF CONTENTS

An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission.

August 29, 2024

Exhibit 5.1 August 29, 2024 The Board of Directors Better Choice Company Inc. 12400 Race Track Road Tampa, Florida 33626 Re: Offering Statement on Form 1-A Ladies and Gentlemen: We have acted as counsel to Better Choice Company Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing of an offering statement on Form 1-A to which this opinion is attached as an exh

Consent of Independent Registered Public Accounting Firm

Exhibit 23.1 Consent of Independent Registered Public Accounting Firm We hereby consent to the use in the Offering Circular constituting a part of this Offering Statement of our report dated April 12, 2024, relating to the consolidated financial statements of Better Choice Company Inc. (the “Company”), which is contained in that Offering Circular. Our report contains an explanatory paragraph regar

PRE-FUNDED COMMON STOCK PURCHASE WARRANT BETTER CHOICE COMPANY INC.

Exhibit 4.9 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

BETTER CHOICE COMPANY INC. ANNOUNCES SECOND QUARTER 2024 RESULTS Net Income Increased 190% to $2.7 million Year-Over-Year EPS Growth of 170% to $2.98 Year-Over-Year Adjusted EBITDA Increased 98% to less than $(0.1) million1 Year-Over-Year Recognized

Exhibit 99.1 BETTER CHOICE COMPANY INC. ANNOUNCES SECOND QUARTER 2024 RESULTS Net Income Increased 190% to $2.7 million Year-Over-Year EPS Growth of 170% to $2.98 Year-Over-Year Adjusted EBITDA Increased 98% to less than $(0.1) million1 Year-Over-Year Recognized $3.6 million Gain on Extinguishment of Debt TAMPA, FL, August 13, 2024 — Better Choice Company Inc. (NYSE American: BTTR) (the “Company”

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 13, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Better Cho

Joint Acquisition Statement Pursuant to Section 240.13d-1(k)

EX-1 2 ex1.htm JOINT ACQUISITION STATEMENT Page 9 of 9 EXHIBIT 1 JOINT ACQUISITION STATEMENT PURSUANT TO SECTION 240.13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of

BTTR / Better Choice Company Inc. / Altium Capital Management LP - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Better Choice Company Inc. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 08771Y402 (CUSIP Number) July 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2024 Better Choice Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

Press release of the Company announcing the pricing, dated July 31, 2024

Exhibit 99.2

Underwriting Agreement, dated July 29, 2024, by and between the Company and ThinkEquity LLC

Exhibit 1.1

Press release of the Company announcing the pricing, dated July 29, 2024

Exhibit 99.1

The date of this prospectus is July 29, 2024 TABLE OF CONTENTS

Filed Pursuant to Rule 424(b)(1) Registration No. : 333-280714 PROSPECTUS 639,000 Shares of Common Stock Pre-Funded Warrants to Purchase 1,028,000 Shares of Common Stock 1,028,000 Shares of Common Stock Underlying Such Pre-Funded Warrants Better Choice Company Inc. This is a firm commitment public offering of 639,000 shares of common stock of Better Choice Company Inc., par value $0.001 per share,

ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004

ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004 July 25, 2024 VIA EDGAR U.

Better Choice Company Inc. 12400 Race Track Road Tampa, FL 33626

Better Choice Company Inc. 12400 Race Track Road Tampa, FL 33626 July 25, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Erin Donahue Re: Better Choice Company Inc. Registration Statement on Form S-1 Filed on July 8, 2024 File No. 333-280714 Ladies and Gentlemen: Pursuant to Rule 461

Better Choice Company Inc. 12400 Race Track Road Tampa, FL 33626

Better Choice Company Inc. 12400 Race Track Road Tampa, FL 33626 July 25, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Erin Donahue Re: Better Choice Company Inc. Registration Statement on Form S-1 Filed on July 8, 2024 File No. 333-280714 Ladies and Gentlemen: Reference is made to

ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004

ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004 July 25, 2024 VIA EDGAR U.

As filed with the U.S. Securities and Exchange Commission on July 23, 2024

As filed with the U.S. Securities and Exchange Commission on July 23, 2024 Registration No. 333-280714 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BETTER CHOICE COMPANY INC. (Exact name of registrant as specified in its charter) delaware 5961 83-4284557 (STATE OR OTHER JURISDICTION OF IN

Better Choice Company Inc. 12400 Race Track Road Tampa, FL 33626

Better Choice Company Inc. 12400 Race Track Road Tampa, FL 33626 July 24, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Erin Donahue Re: Better Choice Company Inc. Registration Statement on Form S-1 Filed on July 8, 2024 File No. 333-280714 Ladies and Gentlemen: Pursuant to Rule 461

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) BETTER CHOICE COMPANY INC.

ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004

ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004 July 24, 2024 VIA EDGAR U.

Form of Representative’s Warrant (included as part of Exhibit 1.1)

Exhibit 1.1 UNDERWRITING AGREEMENT between BETTER CHOICE COMPANY INC. and THINKEQUITY LLC as Representative of the Several Underwriters BETTER CHOICE COMPANY INC. UNDERWRITING AGREEMENT New York, New York July [●], 2024 ThinkEquity LLC As Representative of the several Underwriters named on Schedule 1 attached hereto 17 State Street, 41st Fl New York, NY 10004 Ladies and Gentlemen: The undersigned,

Form of pre-funded and representative warrants in connection with the July 2024 Public Offering

Exhibit 4.9 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 9, 2024 Better Choice Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 9, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission

Press Release, dated July 12, 2024

Exhibit 16.1 Better Choice Company Announces NYSE Acceptance of Plan to Regain Listing Compliance NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announced today that it received a notice on July 9, 2024 from the NYSE American LLC (the “NYSE American”), stating acceptance of the Comp

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 12, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

Letter of BDO USA, P.C., dated July 12, 2024

Exhibit 16.1

LETTER

July 10, 2024 Kent Cunningham Chief Executive Officer Better Choice Co Inc. 12400 Race Track Road Tampa, FL 33626 Re: Better Choice Co Inc. Registration Statement on Form S-1 Filed July 8, 2024 File No. 333-280714 Dear Kent Cunningham: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for accelerati

As filed with the U.S. Securities and Exchange Commission on July 5, 2024

As filed with the U.S. Securities and Exchange Commission on July 5, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BETTER CHOICE COMPANY INC. (Exact name of registrant as specified in its charter) delaware 5961 83-4284557 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATIO

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) BETTER CHOICE COMPANY INC.

Settlement Agreement, dated June 20, 2024, by and between Alphia, Inc. and Better Choice Company, Inc.

Exhibit 10.1

Press Release regarding Debt Retirement dated June 20, 2024

Exhibit 99.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2024 Better Choice Compa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2024 Better Choice Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission

Better Choice Company Receives Letter from NYSE Regulation

Exhibit 99.1 May 24, 2024 Better Choice Company Receives Letter from NYSE Regulation NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announced today that it received a warning letter from NYSE Regulation regarding the Company’s disclosure of material news in a manner that did not compl

Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission

Press Release dated May 17, 2024

Exhibit 99.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Better Ch

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

.

Exhibit 99.1 .

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 Better Choice Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2024 Better Choice Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Exhibit 99.1 Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards NEW YORK, NY, April 29, 2024 — Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announced today that it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) dated Apri

BETTER CHOICE COMPANY, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 32% Year-Over-Year EPS Grew 45% Year-Over-Year

Exhibit 99.1 BETTER CHOICE COMPANY, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 32% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, FLORIDA - April 12, 2024 - Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today reported its finan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2024 Better Choice Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 15, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

Better Choice Company Board of Directors Authorize Stock Repurchase Program

Exhibit 99.1 Better Choice Company Board of Directors Authorize Stock Repurchase Program NEW YORK, NY, April 16, 2024 — Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announces that its Board of Directors has authorized a stock repurchase program under which the Company can repurchase up to $5 million of the currently outstan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Better Choice

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 1, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 20, 2024 Better Choice Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 20, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 26-2754069 (State or other Jurisdiction of Incorporation) (Commissi

Better Choice Company Board of Directors Authorize Stock Repurchase Program

Exhibit 3.1

Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

March 8, 2024

Exhibit 99.1 March 8, 2024 Better Choice Company to Effectuate a Reverse Stock Split TAMPA, Fla., March 08, 2024 (GLOBE NEWSWIRE) - Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that it will proceed with a 1-for-44 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement BETTER CHOICE COMPANY, INC. (Name of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement BETTER CHOICE COMPANY, INC. (Name of

BTTR / Better Choice Company Inc. / HEP Partners LLC - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Better Choice Company Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 08771Y204 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2024 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commis

Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market

Exhibit 99.1 February 9, 2024 Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco Inc. (‘Aimia’). Better Choice will now be in a p

As filed with the Securities and Exchange Commission on January 18, 2024

As filed with the Securities and Exchange Commission on January 18, 2024 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables FORM S-8 REGISTRATION STATEMENT (Form Type) Better Choice Company Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 Better Choice C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Bette

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 Better Choice C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commi

Third Quarter 2023 Revenue Grew 11% Year-Over-Year to $13.1 million Adjusted EBITDA Growth of 95% Year-Over-Year EPS Growth of 77% Year-Over-Year

Exhibit 99.1 BETTER CHOICE COMPANY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS Third Quarter 2023 Revenue Grew 11% Year-Over-Year to $13.1 million Adjusted EBITDA Growth of 95% Year-Over-Year EPS Growth of 77% Year-Over-Year TAMPA, FLORIDA - November 13, 2023 - Better Choice Company, Inc. (“Better Choice” or the “Company”) (NYSE American: BTTR), a pet health and wellness company, today announced it

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 21, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Comm

Better Choice Company Receives NYSE American Notice

Better Choice Company Receives NYSE American Notice TAMPA, FL, September 27, 2023 (GLOBE NEWSWIRE) - Better Choice Company, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

Alphia Second Tranche Warrant

Execution Version Error! Unknown document property name. THIS ISSUANCE OF THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS. THIS WARRANT MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF AT ANY TIME WITHOUT EFFECTIVE REGISTRATION UNDER SUCH ACT AND LAWS OR AN EXEMPTION THEREFROM, AND COMPLIANCE WITH THE OTHER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 28, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

BETTER CHOICE COMPANY INC. ANNOUNCES SECOND QUARTER 2023 RESULTS Enhanced Operational and Financial Discipline 33% Growth in EPS Year-Over-Year Gross Margin Growth of 543 Basis Points Year-Over-Year Increased Operating Margin Growth of 127 Basis Poin

BETTER CHOICE COMPANY INC. ANNOUNCES SECOND QUARTER 2023 RESULTS Enhanced Operational and Financial Discipline 33% Growth in EPS Year-Over-Year Gross Margin Growth of 543 Basis Points Year-Over-Year Increased Operating Margin Growth of 127 Basis Points Year-Over-Year TAMPA, FL, August 21, 2023 - Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and w

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40477 Better Cho

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2023 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

Employment Agreement, dated as of August 2, 2023, by and between Carolina Martinez and Better Choice Company, Inc.

employmentagreementcarol 9498/12/9025418.v3 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of August 2, 2023 (the “Effective Date”) and is entered into by and between Carolina Martinez, residing at 2907 W. San Isidro St., Tampa, FL 33629 (the “Executive”) and Better Choice Company, Inc., a Delaware Corporation, with its principal place of business at 12400 Race Track

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 Better Choice Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissi

Account Purchase Agreement, dated as of June 21, 2023, by and between Wintrust Receivables Finance, a division of Wintrust Bank N.A., and Halo, Purely for Pets, Inc.

a109wintrusthpp-accountp Execution Version Page 1 Account Purchase Agreement 7485589.

Second Tranche Warrant, dated as of June 21, 2023 issued Better Choice Company Inc. to Alphia Inc.

a107alphia-betterchoicec Execution Version Error! Unknown document property name. THIS ISSUANCE OF THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS. THIS WARRANT MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF AT ANY TIME WITHOUT EFFECTIVE REGISTRATION UNDER SUCH ACT AND LAWS OR AN EXEMPTION THEREFROM, AND

Term Loan Security Agreement, dated as of June 21, 2023, by and between Better Choice Company Inc., Halo, Purely for Pets, Inc. and Alphia Inc.

a103alphia-bccxtermloans Execution Version Notwithstanding anything herein to the contrary, the Liens and security interests granted to Alphia Inc.

Term Loan, dated as of June 21, 2023, issued by Better Choice Company Inc. to Alphia Inc.

a102alphia-bccxtermnotes TERM NOTE $5,000,000 June 21, 2023 FOR VALUE RECEIVED, the undersigned (including its permitted successors, the “Borrower”) hereby promises to pay to Alphia Inc.

Term Loan Guaranty, dated as of June 21, 2023, by and between Halo, Purely for Pets, Inc. and Alphia Inc.

a105alphia-bccxtermloang 106383305.4 Execution Version TERM LOAN GUARANTY Dated as of June 21, 2023 among HALO, PURELY FOR PETS, INC. and EACH ADDITIONAL GUARANTOR THAT BECOMES A PARTY HERETO, as Guarantors, and ALPHIA INC., as Lender 106383305.4 TABLE OF CONTENTS Section Page Section 1. Guaranty; Limitation of Liability .............................................................................

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2023 Better Choice Compa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2023 Better Choice Company Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commissio

Unlimited Continuing Guaranty Agreement, dated as of June 21, 2023, by and between Better Choice Company Inc. and Wintrust Receivables Finance, a division of Wintrust Bank N.A.

a1010wintrusthpp-guaran 1 7488515.3 UNLIMITED CONTINUING GUARANTY AGREEMENT This Unlimited Continuing Guaranty Agreement (the "Guaranty") is executed as of June 21, 2023 by Better Choice Company, Inc., a Delaware corporation (the "Guarantor"), for the benefit of Wintrust Receivable Finance, a division of Wintrust Bank ("Wintrust") with an address of 231 South LaSalle Street, Fourth Floor, Chicago,